Study: Many cancer drugs unproven 5 years after accelerated approval
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Related articles
Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
NEW YORK (AP) — Saudi Arabia’s move into tennis will now include a multiyear deal to sponsor the WTA2024-05-21Xinhua Headlines: China, Vietnam Lift Ties to New Stage, Aiming for Shared Future
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Sri Lanka receives batch of China's Sinopharm vaccines
Sri Lankan President Gotabaya Rajapaksa (4th R, front ) attends the handover ceremony of Sinopharm C2024-05-21Bustling Lantern Festival witnesses China's economic vitality and creativity
(ECNS) -- The Lantern Festival, celebrated on the fifteenth day of the first lunar month, falls on F2024-05-21'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
CHICAGO (AP) — The road for Shota Imanaga from Japan to the major leagues included at least one shar2024-05-21Xi Urges Guangxi to Write Its Chapter in Chinese Modernization
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment